Eloxx Pharmaceuticals, Inc. Insider Trading for May 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Eloxx Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Eloxx Pharmaceuticals, Inc. for May 2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 20 2021 | ELOX | Eloxx Pharmaceutic ... | PAREKH RAJESH B | Option Exercise | A | 1.48 | 3,334 | 4,934 | 3,334 | ||
May 20 2021 | ELOX | Eloxx Pharmaceutic ... | Kariv Tomer | Option Exercise | A | 1.48 | 20,000 | 29,600 | 20,000 | ||
May 20 2021 | ELOX | Eloxx Pharmaceutic ... | Seehra Jasbir | Option Exercise | A | 1.48 | 20,000 | 29,600 | 20,000 | ||
May 18 2021 | ELOX | Eloxx Pharmaceutic ... | MODUR VIJAY | HEAD OF R&D | Option Exercise | A | 1.41 | 496,204 | 699,648 | 496,204 | |
May 17 2021 | ELOX | Eloxx Pharmaceutic ... | PAREKH RAJESH B | Director | Buy | P | 1.35 | 2,381,890 | 3,215,552 | 4,827,129 | 2.4 M to 4.8 M (+97.41 %) |
May 17 2021 | ELOX | Eloxx Pharmaceutic ... | PAREKH RAJESH B | Director | Buy | P | 1.35 | 84,776 | 114,448 | 171,807 | 87 K to 171.8 K (+97.41 %) |
May 17 2021 | ELOX | Eloxx Pharmaceutic ... | Pontifax Management 4 G.P. (20 ... | 10% Owner | Buy | P | 1.35 | 592,592 | 799,999 | 616,592 | 24 K to 616.6 K (+2,469.13 %) |
May 17 2021 | ELOX | Eloxx Pharmaceutic ... | Pontifax Management 4 G.P. (20 ... | 10% Owner | Buy | P | 1.35 | 1,422,222 | 1,920,000 | 1,989,551 | 567.3 K to 2 M (+250.69 %) |
May 17 2021 | ELOX | Eloxx Pharmaceutic ... | Pontifax Management 4 G.P. (20 ... | 10% Owner | Buy | P | 1.35 | 2,630,487 | 3,551,157 | 3,679,797 | 1 M to 3.7 M (+250.69 %) |
May 17 2021 | ELOX | Eloxx Pharmaceutic ... | Pontifax Management 4 G.P. (20 ... | 10% Owner | Buy | P | 1.35 | 1,280,624 | 1,728,842 | 1,791,470 | 510.8 K to 1.8 M (+250.69 %) |
May 17 2021 | ELOX | Eloxx Pharmaceutic ... | Nussbaum Ran | Director | Buy | P | 1.35 | 592,592 | 799,999 | 616,592 | 24 K to 616.6 K (+2,469.13 %) |
May 17 2021 | ELOX | Eloxx Pharmaceutic ... | Nussbaum Ran | Director | Buy | P | 1.35 | 1,422,222 | 1,920,000 | 1,989,551 | 567.3 K to 2 M (+250.69 %) |
May 17 2021 | ELOX | Eloxx Pharmaceutic ... | Nussbaum Ran | Director | Buy | P | 1.35 | 2,630,487 | 3,551,157 | 3,679,797 | 1 M to 3.7 M (+250.69 %) |
May 17 2021 | ELOX | Eloxx Pharmaceutic ... | Nussbaum Ran | Director | Buy | P | 1.35 | 1,280,624 | 1,728,842 | 1,791,470 | 510.8 K to 1.8 M (+250.69 %) |
May 17 2021 | ELOX | Eloxx Pharmaceutic ... | Kariv Tomer | Director | Buy | P | 1.35 | 592,592 | 799,999 | 616,592 | 24 K to 616.6 K (+2,469.13 %) |
May 17 2021 | ELOX | Eloxx Pharmaceutic ... | Kariv Tomer | Director | Buy | P | 1.35 | 1,422,222 | 1,920,000 | 1,989,551 | 567.3 K to 2 M (+250.69 %) |
May 17 2021 | ELOX | Eloxx Pharmaceutic ... | Kariv Tomer | Director | Buy | P | 1.35 | 2,630,487 | 3,551,157 | 3,679,797 | 1 M to 3.7 M (+250.69 %) |
May 17 2021 | ELOX | Eloxx Pharmaceutic ... | Kariv Tomer | Director | Buy | P | 1.35 | 1,280,624 | 1,728,842 | 1,791,470 | 510.8 K to 1.8 M (+250.69 %) |
May 03 2021 | ELOX | Eloxx Pharmaceutic ... | Belloff Neil S. | COO, GENERAL COUNSE ... | Option Exercise | M | 0.00 | 1,562 | 0 | 10,938 | |
May 03 2021 | ELOX | Eloxx Pharmaceutic ... | Belloff Neil S. | COO, GENERAL COUNSE ... | Payment of Exercise | F | 2.18 | 459 | 1,001 | 27,180 | 27.6 K to 27.2 K (-1.66 %) |
May 03 2021 | ELOX | Eloxx Pharmaceutic ... | Belloff Neil S. | COO, GENERAL COUNSE ... | Buy | M | 0.00 | 1,562 | 0 | 27,639 | 26.1 K to 27.6 K (+5.99 %) |